CLINICAL_TRIALS
trial_result
· 2019-04-26
Clinical Trial Update: Efficacy, Security, Adherence, Tolerability and Cost Effectiveness of Latent TB Treatment in Patients With TB/DM2 (TBL) [Phase 4]
Summary
Phase 4 clinical trial evaluating efficacy, safety, adherence, tolerability, and cost-effectiveness of latent TB treatment in patients with diabetes mellitus an…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Instituto Nacional de Salud Publica, Mexico | Conditions: Diabetes Mellitus, Tuberculin (Skin Test) Positive | Phase 4 | Status: COMPLETED